Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing

por Argüelles-Arias, Federico, Valdés Delgado, Teresa, Maldonado Pérez, Belén, González Antuña, Jaime, Castro Laria, Luisa
Publicado 2023

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

por Guerra Veloz, María Fernanda, Belvis Jiménez, María, Valdes Delgado, Teresa, Castro Laria, Luisa, Maldonado Pérez, Belén, Perea Amarillo, Raúl, Merino Bohórquez, Vicente, Caunedo Álvarez, Ángel, Vilches Arenas, Ángel, Argüelles-Arias, Federico
Publicado 2019